Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services

American Journal of Medical Genetics, Part A

Volumn 158 A, Issue 3, 2012, Pages 588-596

  Hoeltzenbein, Maria ^a   Elefant, Elisabeth ^b   Vial, Thierry ^c   Finkel Pekarsky, Victoriya ^d   Stephens, Sally ^e   Clementi, Maurizio ^f   Allignol, Arthur ^g   Weber Schoendorfer, Corinna ^a   Schaefer, Christof ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Centre Renseignement sur les Agents Teratogenes (CRAT)   (France)

^c Centre de Pharmacovigilance de Lyon   (France)

^d Israel Teratogen Information Service   (Israel)

^e UK Teratology Information Service   (United Kingdom)

^f Servizio Informazione Terologica   (Italy)

^g UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Birth defects; Congenital anomalies; Drug induced abnormalities; Immunosuppressant drug; Mycophenolate mofetil; Mycophenolic acid; Pregnancy outcome; Prospective study; Spontaneous abortion; Teratogens

Indexed keywords

ABATACEPT; ACEBUTOLOL; ACETYLSALICYLIC ACID; ALENDRONIC ACID; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ENALAPRIL; ESCITALOPRAM; FOSFOMYCIN; HYDROXYCHLOROQUINE; LORAZEPAM; METHYLDOPA; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NAPROXEN; PERINDOPRIL; PREDNISOLONE; PREDNISONE; TACROLIMUS; URSODEOXYCHOLIC ACID; VALACICLOVIR; ZOLPIDEM;

ADULT; ARTICLE; ATRESIA; AUTOIMMUNE DISEASE; CASE STUDY; CONTROLLED STUDY; EMBRYO; EMBRYOPATHY; EXTERNAL EAR CANAL ATRESIA; EXTERNAL EAR MALFORMATION; FEMALE; FETUS; HEART ATRIUM SEPTUM DEFECT; HUMAN; HYDRONEPHROSIS; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; INFANT; KIDNEY GRAFT REJECTION; LIVER GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; MENINGOMYELOCELE; MICROTIA; MULTIPLE MALFORMATION SYNDROME; PREGNANCY; PREGNANCY TERMINATION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TERATOGENICITY; TRACHEOESOPHAGEAL ATRESIA;

ABORTION, SPONTANEOUS; CONGENITAL ABNORMALITIES; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; MYCOPHENOLIC ACID; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; TERATOGENS;

EID: 84857116422     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35223     Document Type: Article

References (21)

1. Anderka MT, Lin AE, Abuelo DN, Mitchell AA, Rasmussen SA. 2009. Reviewing the evidence for mycophenolate mofetil as a new teratogen: Case report and review of the literature. Am J Med Genet Part A 149A: 1241- 1248.
2. Ang GS, Simpson SA, Reddy AR. 2008. Mycophenolate mofetil embryopathy may be dose and timing dependent. Am J Med Genet Part A 146A: 1963- 1966.
3. Coscia LA, Constantinescu S, Moritz MJ, Frank A, Ramirez CB, Maley WL, Doria C, Mcgrory CH, Armenti VT. 2009. Report from the National Transplantation Pregnancy Registry (NTPR): Outcomes of pregnancy after transplantation. Clin Transpl 103- 122.
4. El Sebaaly Z, Charpentier B, Snanoudj R. 2007. Fetal malformations associated with mycophenolate mofetil for lupus nephritis. Nephrol Dial Transplant 22: 2722.
5. Goldstein LH, Dolinsky G, Greenberg R, Schaefer C, Cohen-Kerem R, Diav-Citrin O, Malm H, Reuvers-Lodewijks ME, Rost van Tonningen-van Driel MM, Arnon J, Ornoy A, Clementi M, Di Gianantonio E, Koren G, Braunstein R, Berkovitch M. 2007. Pregnancy outcome of women exposed to azathioprine during pregnancy. Birth Defects Res A Clin Mol Teratol 79: 696- 6701.
6. Johnson KA, Weber PA, Jones KL, Chambers CD. 2001. Selection bias in Teratology Information Service pregnancy outcome studies. Teratology 64: 79- 82.
7. Klieger-Grossmann C, Chitayat D, Lavign S, Kao K, Garcia-Bournissen F, Quinn D, Luo V, Sermer M, Riordan S, Laskin C, Matok I, Gorodischer R, Chambers C, Levi A, Koren G. 2010. Prenatal exposure to mycophenolate mofetil: An updated estimate. J Obstet Gynaecol Can 32: 794- 797.
8. Lin AE, Singh KE, Strauss A, Nguyen S, Rawson K, Kimonis VE. 2011. An additional patient with mycophenolate mofetil embryopathy: Cardiac and facial analyses. Am J Med Genet Part A 155A: 748- 756.
9. Martinez-Frias ML, Rodriguez-Pinilla E. 1999. Problems of using data from Teratology Information Services (TIS) to identify putative teratogens. Teratology 60: 54- 55.
10. Meister R, Schaefer C. 2008. Statistical methods for estimating the probability of spontaneous abortion in observational studies-analyzing pregnancies exposed to coumarin derivatives. Reprod Toxicol 26: 31- 35.
11. Merks JH, van Karnebeek CD, Caron HN, Hennekam RC. 2003. Phenotypic abnormalities: Terminology and classification. Am J Med Genet Part A 123A: 211- 230.
12. Merlob P, Stahl B, Klinger G. 2009. Tetrada of the possible mycophenolate mofetil embryopathy: A review. Reprod Toxicol 28: 105- 108.
13. Ornoy A, Mastroiacovo P. 2000. More on data from teratogen information systems (TIS). Teratology 61: 327- 328.
14. Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA. 2003. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 67: 193- 201.
15. Roche Laboratories U. 2007. Important changes in the CellCept [mycophenolate mofetil] prescribing information. Use of CellCept is associated with increased pregnancy loss and congenital malformations/change from pregnancy category C to pregnancy category D. Available at:
16. Schaefer C, Ornoy A, Clementi M, Meister R, Weber-Schoendorfer C. 2008. Using observational cohort data for studying drug effects on pregnancy outcome-methodological considerations. Reprod Toxicol 26: 36- 41.
17. Sifontis NM, Coscia LA, Constantinescu S, Lavelanet AF, Moritz MJ, Armenti VT. 2006. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 82: 1698- 1702.
18. Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. 2010. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 5: 2060- 2068.
19. Tendron A, Gouyon JB, Decramer S. 2002. In utero exposure to immunosuppressive drugs: Experimental and clinical studies. Pediatr Nephrol 17: 121- 130.
20. Tjeertes IF, Bastiaans DE, van Ganzewinkel CJ, Zegers SH. 2007. Neonatal anemia and hydrops fetalis after maternal mycophenolate mofetil use. J Perinatol 27: 62- 64.
21. Voigt M, Rochow N, Hesse V, Olbertz D, Schneider KT, Jorch G. 2010. Kurzmitteilung zu den Perzentilenwerten für die Körpermaße der Neugeborenen. Z Geburtshilfe Neonatol 214: 24- 29.